Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
Quintiles – Articles
QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.
ESMO review: advances in immunotherapy, EMA dialogue and patient power
Infographic: Solving the challenges of immuno-oncology trials
In the last two years, the first PD-1 checkpoint inhibitor drugs to reach patients have launched a revolution in cancer care.
Immuno-oncology: how to keep ahead in a fast-moving field
On Demand: The Top 5 Challenges in Immuno-Oncology Trials